Global medical tourism remains overwhelmingly underpenetrated. While the industry has grown, most participants are still competing for the same small segment of price-sensitive self-pay patients—creating a race to the bottom on cost rather than building scalable systems of care.

‍

Yet the real opportunity is far larger and largely untapped: multinational employers, global insurers, sovereign funds, brokers, and cross-border healthcare partners who want structured domestic and international solutions for complex care and specialty treatments—but cannot deploy them at scale due to fragmentation, inconsistent standards, unclear risk models, and lack of integration.

‍

This keynote challenges leaders to rethink the market entirely.

‍

Key themes include:

• Why over 90% of global healthcare mobility opportunity remains unrealized
• The limitations of price-driven competition
• The global enterprise demand for complex care and specialty drug cost reduction
• Domestic and cross-border centers of excellence as complementary strategies
• Structural barriers preventing multinational adoption
• The need for payment infrastructure, transparency, and risk alignment
• Moving from transactional referrals to integrated global healthcare systems